Insulin analogues and severe hypoglycaemia in type 1 diabetes

Autor: Kristensen, P.L., Hansen, L.S., Jespersen, M.J., Pedersen-Bjergaard, U., Beck-Nielsen, H., Christiansen, J.S., Nørgaard, K., Perrild, H., Parving, H.-H., Thorsteinsson, B., Tarnow, L.

Publikováno v: In Diabetes Research and Clinical Practice April 2012 96(1):17-23

Effect of insulin degludec vs insulin glargine U100 on occurrence of nocturnal hypoglycaemia assessed by plasma glucose profiles in people with type 1 diabetes: HypoDeg trial

Autor: Brosen, J. M. B., Agesen, R. M., Kristensen, P. L., Alibegovic, A. C., Andersen, H. U., Beck-Nielsen, H., Gustenhoff, P., Hedetoft, C., Jensen, T., Juhl, C. B., Lerche, S. S., Norgaard, K., Parving, H. -H., Tarnow, L., Pedersen-Bjergaard, U.

Publikováno v: Brosen, J M B, Agesen, R M, Kristensen, P L, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Norgaard, K, Parving, H-H, Tarnow, L & Pedersen-Bjergaard, U 2021, ' Effect of insulin degludec vs insulin glargine U100 on occurrence of nocturnal hypoglycaemia assessed by plasma glucose profiles in people with type 1 diabetes: HypoDeg trial ', Diabetologia, vol. 64, no. Suppl. 1, 516, pp. 270-271 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::b5416af8a3378d571b9482272bc6f40e
https://portal.findresearcher.sdu.dk/da/publications/49288c4f-98c4-4951-a641-ac7bfa2565c2

The PPARγ2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy

Autor: Jorsal, A., Tarnow, L., Lajer, M., Ek, J., Hansen, T., Pedersen, O., Parving, H.-H.

Publikováno v: In Molecular Genetics and Metabolism July 2008 94(3):347-351

Comparison of Insulin Degludec and Glargine U100 in Patients with Type 1 Diabetes Prone to Severe Nocturnal Hypoglycaemia

Autor: Agesen, R, Alibegovic, A, Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Hansen, T, Hedetoft, C, Jensen, T, Juhl, C, Kryger, A, Lerche, S, Norgaard, K, Parving, H -H., Sorensen, A, Tarnow, L, Thorsteinsson, B, Pedersen-Bjergaard, U

Publikováno v: Agesen, R, Alibegovic, A, Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Hansen, T, Hedetoft, C, Jensen, T, Juhl, C, Kryger, A, Lerche, S, Norgaard, K, Parving, H-H, Sorensen, A, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2020, ' Comparison of Insulin Degludec and Glargine U100 in Patients with Type 1 Diabetes Prone to Severe Nocturnal Hypoglycaemia ', Diabetes Technology & Therapeutics, vol. 22, no. Suppl. 1, pp. A93-A94 . < http://doi.org/10.1089/dia.2020.2525.abstracts >
Agesen, R, Alibegovic, A, Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Hansen, T, Hedetoft, C, Jensen, T, Juhl, C, Kryger, A, Lerche, S, Norgaard, K, Parving, H-H, Sorensen, A, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2020, ' Comparison of insulin degludec and glargine U100 in patients with type 1 diabetes prone to severe nocturnal hypoglycaemia ', Diabetes Technology & Therapeutics, vol. 22, no. Suppl. 1, pp. A93-A94 . https://doi.org/10.1089/dia.2020.2525.abstracts

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::318238c68209ed364d316f985b988b4e
https://portal.findresearcher.sdu.dk/da/publications/9e2449cd-4bad-4f6b-b0a6-d86ac285efbb

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.